Showing results (2041-2050 of 2,055) with videos related to

Sort By:
Pageof 206
Frontiers in Public Health|January 10, 2022
Epidemiological Characteristics and Transmissibility of Human Immunodeficiency Virus in Nanning City, China, 2001-2020Qian Lin, Bin Deng, Jia Rui, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Infectious Diseases of Poverty|December 29, 2021
The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, ChinaZe-Yu Zhao, Yan Niu, Li Luo, et al.
BMC Infectious Diseases|March 1, 2014
Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, ChinaNing Wen, Chun-Xiang Fan, Jian-Ping Fu, et al.
Journal of the American College of Cardiology|October 10, 2024
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized TrialMingtong Xu, Zhen Wang, Yumin Zhang, et al.
Nature Communications|August 11, 2021
Automatic detection of 39 fundus diseases and conditions in retinal photographs using deep neural networksLing-Ping Cen, Jie Ji, Jian-Wei Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 31, 2026
Modification of the VP1u region boosts transduction of adeno-associated virus vectors for ocular gene therapyMengtian Cui, Shun-Yun Cheng, Jialing Liang, et al.
Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.
British Journal of Cancer|September 6, 2025
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysisYejin Mok, Aditya Surapaneni, Yingying Sang, et al.
Nature Communications|July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trialDean A Fennell, Kayleigh Hill, Min Zhang, et al.
Pageof 206